The term Pre-Exposure Prophylaxis (PrEP) refers to an HIV prevention practice in which persons not infected with HIV who are at high risk of the disease take antiretroviral medication in an attempt to lower their chances of becoming infected if exposed.
The Centers for Disease Control and Prevention (CDC) recommend PrEP for HIV-uninfected patients with any of the following indications:
It is recommended that providers tell all sexually active patients about PrEP and how it can protect them from getting HIV. Providers should prescribe PrEP to anyone who asks for it, including sexually active adults and adolescents who do not report behaviors that put them at risk for getting HIV.
Pre-exposure Prophylaxis for the Prevention of HIV in the United States – 2021
Quick Guide: 2021 PrEP Update – Download Factsheet
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society–USA Panel
Centers for Disease Control and Prevention (CDC) Guideline Report on PrEP
CDC Interim Guidance on PrEP use in MSM
PrEPLine – Call for a Phone Consultation: (855) 448-7737 or (855) HIV-PrEP Mon-Fri, 9am – 8pm ET